Veterinary Pathologist, Early Drug Discovery

F. Hoffmann-La Roche AG; Basel; Vor Ort; CHF 130.000 - 190.000; Vollzeit

Zusammenfassung

Roche seeks a board-certified Veterinary Pathologist to advance tissue and spatial technologies within the 360 Labs framework. The role focuses on pathological evaluation of preclinical studies, collaboration across therapeutic areas, and contributing to platform operations through strategic input and capacity planning.

Ideal candidates hold a DVM with ECVP/ACVP, have 3+ years in academia or biotech, and are fluent in English.

Qualifikationen

• DVM degree with board certification (ECVP/ACVP) and 3+ years of experience in academia or pharma.
• Extensive diagnostic and analytical skills in preclinical animal models.
• Collaborative and team-focused mindset to support platform operations.

Aufgaben

• Execute pathological evaluation of preclinical studies in early discovery and target assessment.
• Serve as the point of contact for anatomical, physiological, and pathological consultations.
• Partner with Platform Head to drive operational success, capacity evaluation and resource planning.
• Interface with 360 Labs pathology groups and related initiatives across pRED.
• Stay current with literature and novel histology/digital pathology approaches; present findings when appropriate.

Kenntnisse

DVM degree

Board-certified (ECVP/ACVP)

3+ years experience (academic/pharma)

Diagnostic skills

Analytical skills

Ausbildung

DVM degree

Jobbeschreibung

## Veterinary Pathologist, Early Drug DiscoveryApplylocations: Baseltime type: Full timeposted on: Posted Todayjob requisition id: 202607-119477At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.### ### The PositionIn Roche’s Pharmaceutical Research and Early Development organisation (pRED), we make transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicines. Together, we create a culture defined by curiosity, responsibility, and humility, where our talented people are empowered and inspired to bring forward extraordinary life-changing innovation at speed.Strategy, Portfolio & Operations (SPO) is a unified function that serves as the strategic and operational backbone enabling pRED's strategy from lab to clinic. Operating under a dynamic Chapter Model, SPO centralises specialised skills across critical areas including Sites & Lab Services, Program & Project Management, Strategy, Clinical Operations, External Operations, Capability Development, Core Lab Technology Platforms (360 Labs) and Asset Team Leadership. SPO’s mission is to drive enterprise value creation by delivering operational excellence and accelerating portfolio productivity. As a trusted partner, SPO fosters a culture of collaboration and accountability to ensure pRED transitions assets smoothly from early research to late-stage development.360 Labs Chapter at a Glance - The primary mission of the 360 Labs Chapter within SPO is to provide greater access and support for the use of cutting-edge biomedical research technologies by scientists across our discovery portfolio. 360 Labs delivers core scientific technologies, expertise and enabling activities, as well as facilitating knowledge sharing in close collaboration with our therapeutic areas and functions. Our ambition is to bring to life a thriving workplace environment, where your collaborative mindset is as valued as your professional expertise. Our goal is to act as a highly integrated ecosystem, supporting research and development, working collaboratively, and focused on fostering excellence and sustainability. Together, these efforts will serve to increase the speed, enhance the robustness and improve the sustainability of our exploratory research and early discovery activities.### The OpportunityThe Tissue & Spatial Technologies Platform in the 360 Labs Initiative is seeking to add a highly motivated and collaborative board-certified Veterinary Pathologist to its team. The successful candidate will possess robust knowledge of preclinical animal model anatomy and physiology, extensive analytical and diagnostic skills, and a passion for working in the laboratory. You will work with a sense of urgency as a part of a matrix team, collaborating with scientists from each of our therapeutic disease areas and functions to propel drug discovery projects forward, whilst also contributing to the ongoing development and operations of the Tissue & Spatial Technologies Platform within the pRED organisation.Your Role and Responsibilities:* You will execute pathological evaluation of preclinical studies in the target assessment and early discovery phases of drug development projects, and you will be the point of contact for anatomical, physiological, and pathological consultations for scientists both within the 360 Labs, as well as collaborating scientists from each of our therapeutic areas;* You act as a strategic partner to the Platform Head to drive our operational success, collaborating on capacity evaluation, gap analyses, and the management of incoming project requests;* You will act as the primary interface between the 360 Labs Tissue & Spatial Technologies Platform and other pRED-internal pathology groups and initiatives;* You will embrace a culture of continuous learning by actively engaging with the latest scientific literature to stay at the forefront of emergent histology and (digital) pathology technologies and approaches; present findings and updates to internal stakeholders and at scientific conferences (where appropriate), ensuring cutting-edge expertise is cultivated and maintained.### Who You Are* You hold a DVM graduate degree, ideally holding a board certification from a recognised body (ECVP/ACVP), with at least 3 years of professional experience in an academic setting and/or the pharmaceutical industry/biotech sector;* You possess extensive diagnostic and analytical skills in preclinical animal models and are generally interested in applying your knowledge outside of traditional boundaries;* You are enthusiastic about working in a team and supporting your co-workers with your expertise, integrating into the platform's daily operations as a highly accessible and collaborative partner.In addition to your scientific expertise and critical technical skills, we are looking for candidates who are:* Customer-focused with a drive for growth and a questioning mindset. Skilled in creative problem-solving, organisation, and implementing innovative ideas efficiently in a fast-paced research context;* Excellent communicators with a high fluency in English, a desire to continuously build a personal network and the ability to thrive in a dynamic, inclusive environment which gives you full accountability for your own contributions and development.At Roche, we aim high to deliver life-changing healthcare solutions. If you’re ready to make a meaningful impact on patients and healthcare systems worldwide, this is the place for you.### Who we areA healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.Let’s build a healthier future, together.**Roche is an Equal Opportunity Employer.**### About UsWe believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.That is why we come to work each day. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.We are proud of who we are, what we do, and how we do it. We are many, working as one across functions, across companies, and across the world.**We are Roche.**